Liver transplant outcome: a comparison between high and low MELD score recipients

被引:8
作者
David, Andre Ibrahim [1 ]
Villela Coelho, Maria Paula [2 ]
Paes, Angela Tavares [2 ]
Leite, Ana Kober [1 ]
Della Guardia, Bianca [2 ]
de Almeida, Marcio Dias [2 ]
Meira, Sergio Paiva [2 ]
de Rezende, Marcelo Bruno [2 ]
Afonso, Rogerio Carballo [2 ]
Ferraz-Neto, Ben-Hur [2 ]
机构
[1] Univ Sao Paulo, Hosp Clin, Fac Med, Sao Paulo, SP, Brazil
[2] Hosp Israelita Albert Einstein, Ave Albert Einstein 627,Consultorio 208,Bloco A1, Sao Paulo, SP, Brazil
来源
EINSTEIN-SAO PAULO | 2012年 / 10卷 / 01期
关键词
Liver transplantation; End stage liver disease; Severity of illness index; Renal insufficiency; Glomerular filtration rate; Treatment outcome;
D O I
10.1590/S1679-45082012000100012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To compare low and high MELD scores and investigate whether existing renal dysfunction has an effect on transplant outcome. Methods: Data was prospectively collected among 237 liver transplants (216 patients) between March 2003 and March 2009. Patients with cirrhotic disease submitted to transplantation were divided into three groups: MELD >= 30, MELD < 30, and hepatocellular carcinoma. Renal failure was defined as a +/- 25% decline in estimated glomerular filtration rate as observed 1 week after the transplant. Median MELD scores were 35, 21, and 13 for groups MELD >= 30, MELD < 30, and hepatocellular carcinoma, respectively. Results: Recipients with MELD >= 30 had more days in Intensive Care Unit, longer hospital stay, and received more blood product transfusions. Moreover, their renal function improved after liver transplant. All other groups presented with impairment of renal function. Mortality was similar in all groups, but renal function was the most important variable associated with morbidity and length of hospital stay. Conclusion: High MELD score recipients had an improvement in the glomerular filtration rate after 1 week of liver transplantation.
引用
收藏
页码:57 / 61
页数:5
相关论文
共 29 条
[1]   Value of the MELD score for the assessment of pre- and post-liver transplantation survival [J].
Adler, M ;
De Gendt, E ;
Vereerstraeten, P ;
Degré, D ;
Bourgeois, N ;
Boon, N ;
Gelin, M ;
Ickx, B ;
Donckier, V .
TRANSPLANTATION PROCEEDINGS, 2005, 37 (06) :2863-2864
[2]  
[Anonymous], LIVER RECIPIENTS DAT
[3]  
[Anonymous], 2009, LIV REC ALL ABO
[4]  
Associacao Brasileira de Transplante de Orgaos, 2009, REGISTRO BRASILEIRO
[5]   A systematic review of the performance of the Model for End-Stage Liver Disease (MELD) in the setting of liver transplantation [J].
Cholongitas, Evangelos ;
Marelli, Laura ;
Shusang, Vibhakorn ;
Senzolo, Marco ;
Rolles, Keith ;
Patch, David ;
Burroughs, Andrew K. .
LIVER TRANSPLANTATION, 2006, 12 (07) :1049-1061
[6]   Chronic renal dysfunction late after liver transplantation [J].
Cohen, AJ ;
Stegall, MD ;
Rosen, CB ;
Wiesner, RH ;
Leung, N ;
Kremers, WK ;
Zein, NN .
LIVER TRANSPLANTATION, 2002, 8 (10) :916-921
[7]   Predicting outcome after liver transplantation: Utility of the model for end-stage liver disease and a newly derived discrimination function [J].
Desai, NM ;
Mange, KC ;
Crawford, MD ;
Abt, PL ;
Frank, AM ;
Markmann, JW ;
Velidedeoglu, E ;
Chapman, WC ;
Markmann, JF .
TRANSPLANTATION, 2004, 77 (01) :99-106
[8]   Mycophenolate Mofetil Monotherapy for Severe Side Effects of Calcineurin Inhibitors Following Liver Transplantation [J].
Dharancy, S. ;
Iannelli, A. ;
Hulin, A. ;
Declerck, N. ;
Schneck, A. S. ;
Mathurin, P. ;
Boleslawski, E. ;
Gugenheim, J. ;
Pruvot, F. R. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (03) :610-613
[9]   K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification - Foreword [J].
Eknoyan, G ;
Levin, NW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) :S14-S266
[10]   Analysis of liver transplantation outcome in patients with MELD score ≥30 [J].
Ferraz-Neto, B. H. ;
Zurstrassen, M. P. V. C. ;
Hidalgo, R. ;
Meira-Filho, S. P. ;
Rezende, M. B. ;
Paes, A. T. ;
Afonso, R. C. .
TRANSPLANTATION PROCEEDINGS, 2008, 40 (03) :797-799